Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,477
  • Shares Outstanding, K 5,365
  • Annual Sales, $ 8,510 K
  • Annual Income, $ -16,490 K
  • EBIT $ -22 M
  • EBITDA $ -19 M
  • 60-Month Beta 1.55
  • Price/Sales 0.99
  • Price/Cash Flow N/A
  • Price/Book 0.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +587,747.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0600 +37.74%
on 05/30/25
2.4200 -39.67%
on 06/10/25
+0.1900 (+14.96%)
since 05/20/25
3-Month
0.9500 +53.68%
on 04/17/25
2.4200 -39.67%
on 06/10/25
+0.0800 (+5.80%)
since 03/20/25
52-Week
0.9500 +53.68%
on 04/17/25
7.1900 -79.69%
on 07/02/24
-4.6910 (-76.26%)
since 06/20/24

Most Recent Stories

More News
Evogene: Q1 Earnings Snapshot

Evogene: Q1 Earnings Snapshot

EVGN : 1.4600 (-7.59%)
Evogene: Q4 Earnings Snapshot

Evogene: Q4 Earnings Snapshot

EVGN : 1.4600 (-7.59%)
Evogene: Q3 Earnings Snapshot

Evogene: Q3 Earnings Snapshot

EVGN : 1.4600 (-7.59%)
Evogene Provides Operational Update Amidst Current Security Situation in Israel

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 1.4600 (-7.59%)
Casterra Delivers First Shipment of Castor Seeds to Africa

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN)...

EVGN : 1.4600 (-7.59%)
Evogene Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...

EVGN : 1.4600 (-7.59%)
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 1.4600 (-7.59%)
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering

/PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based...

EVGN : 1.4600 (-7.59%)
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience

/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and a leading ag-biologicals company that develops microbiome-based,...

CTVA : 73.72 (-0.54%)
EVGN : 1.4600 (-7.59%)
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (NASDAQ: EVGN)...

EVGN : 1.4600 (-7.59%)

Business Summary

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene...

See More

Key Turning Points

3rd Resistance Point 1.7207
2nd Resistance Point 1.6453
1st Resistance Point 1.5527
Last Price 1.4600
1st Support Level 1.3847
2nd Support Level 1.3093
3rd Support Level 1.2167

See More

52-Week High 7.1900
Fibonacci 61.8% 4.8063
Fibonacci 50% 4.0700
Fibonacci 38.2% 3.3337
Last Price 1.4600
52-Week Low 0.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar